Targeting the COX1/2-Driven thromboxane A2 pathway suppresses Barrett's esophagus and esophageal adenocarcinoma development

Zhang, TS; Wang, QS; Ma, WY; Wang, KK; Chang, XY; Johnson, ML; Bai, RH; Bode, AM; Foster, NR; Falk, GW; Limburg, PJ; Iyer, PG; Dong, ZG

Dong, ZG (reprint author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.

EBIOMEDICINE, 2019; 49 (): 145

Abstract

Background: Barrett's esophagus (BE), a complication of gastroesophageal reflux disease (GERD), predisposes patients to esophageal adenocarcinoma (EAC......

Full Text Link